Evidence map›Paper›PMID 34722361›Full record

ArticleGerms2021

COVID-19 in Nigeria: account of epidemiological events, response, management, preventions and lessons learned.

Henshaw Uchechi Okoroiwu, Christopher Ogar Ogar, Glory Mbe Egom Nja, Dennis Akongfe Abunimye, Regina Idu Ejemot-Nwadiaro

Abstract read
In one paragraph

Article in Germs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Henshaw Uchechi OkoroiwuPh.D, MSc, B.MLS, Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, Arthur Jarvis University, Akpabuyo, Nigeria, Hematology Unit, Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, University of Calabar, PMB 1115 Calabar, Nigeria.
Christopher Ogar OgarMSc, B.MLS, Hematology Unit, Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, University of Calabar, PMB 1115 Calabar, Nigeria.
Glory Mbe Egom NjaPh.D, MPH, B.Sc, PGDE. Department of Public Health, Faculty of Allied Medical Sciences, University of Calabar, PMB 1115 Calabar, Nigeria.
Dennis Akongfe AbunimyeB.MLS, Hematology Unit, Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, University of Calabar, PMB 1115 Calabar, Nigeria.
Regina Idu Ejemot-NwadiaroPh.D, M.Sc, B.Sc, Department of Public Health, Faculty of Allied Medical Sciences, University of Calabar, PMB 1115 Calabar, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAfter the World Health Organization declared COVID-19 a pandemic, a hand full of cases and deaths have been recorded globally, Nigeria inclusive.

methodsA retrospective analysis of the COVID-19 weekly disease update report by the Nigeria Centre for Disease Control (NCDC) covering February 29, 2020 (Week 9) and March 28, 2021 (Week 12) was adopted for this study. Data were curated from the NCDC database.

resultsAs of March 28, 2021, Nigeria is the 5

conclusionsCOVID-19 has been reported in all states in Nigeria as well as the Federal Capital Territory with many of the cases involving males. The case trend showed a bimodal form indicating a second wave occurrence. Nigeria government has initiated some combative measures as well as vaccine initiation.

Indexed as

coronavirusCOVID-19COVID-19 in NigeriapandemicSARS-CoV-2

Identifiers

PMID34722361
PMCPMC8548039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.